Inflammation marker and risk of pancreatic cancer: A nested case-control study within the EPIC cohort

British Journal of Cancer

Volumn 106, Issue 11, 2012, Pages 1866-1874

  Grote, V A ^a   Kaaks, R ^a   Nieters, A ^a,b   Tjonneland A ^c   Halkjaer J ^c   Overvad, K ^d   Skjelbo Nielsen, M R ^e   Boutron Ruault, M C ^f,g   Clavel Chapelon, F ^f,g   Racine, A ^f,g   Teucher, B ^a   Becker, S ^a,h   Pischon, T ⁱ   Boeing, H ^j   Trichopoulou, A ^k,l   Cassapa, C ^l   Stratigakou, V ^l   Palli, D ^m   Krogh, V ⁿ   Tumino, R ^o   Vineis, P ^p,q   Panico, S ^r   Rodriguez L ^s   Duell, E J ^t,u   Sanchez M J ^u,v   Dorronsoro, M ^u,w   Navarro, C ^u,x   Gurrea, A B ^u,y   Siersema, P D ^z   Peeters, P H M ^p,z   Ye, W ^aa,ab   Sund, M ^ab   Lindkvist, B ^ac   Johansen, D ^ad   Khaw, K T ^ae   Wareham, N ^af   Allen, N E ^ag   Travis, R C ^ag   Fedirko, V ^ah   Jenab, M ^ah   Michaud, D S ^p,ai   Chuang, S C ^p   Romaguera, D ^p   Bueno De Mesquita, H B ^z,aj   Rohrmann, S ^a,ak   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g UNIVERSITÉ PARIS SACLAY   (France)

^h UNIVERSITY HOSPITAL LEIPZIG   (Germany)

ⁱ MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^j GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^k UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^l HELLENIC HEALTH FOUNDATION   (Greece)

^m CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

ⁿ NATIONAL CANCER INSTITUTE   (Italy)

^o CIVILE M P AREZZO HOSPITAL   (Italy)

^p IMPERIAL COLLEGE LONDON   (United Kingdom)

^q HuGeF Foundation   (Italy)

^r UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^s Health and Health Care Services Council   (Spain)

^t CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^u CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^v ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^w Basque Government   (Spain)

^x Murcia Regional Health Authority   (Spain)

^y INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^z UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^aa KAROLINSKA INSTITUTE   (Sweden)

^ab UMEÅ UNIVERSITY   (Sweden)

^ac UNIVERSITY OF GOTHENBURG   (Sweden)

^ad LUND UNIVERSITY HOSPITAL   (Sweden)

^ae UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^af MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^ag UNIVERSITY OF OXFORD   (United Kingdom)

^ah INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^ai BROWN UNIVERSITY   (United States)

^aj NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^ak UNIVERSITY OF ZURICH   (Switzerland)

more..

Author keywords

CRP; EPIC; IL 6; inflammation; pancreatic cancer; TNF receptor

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PANCREAS CANCER; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RECEPTORS, TUMOR NECROSIS FACTOR; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84861442915     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.172     Document Type: Article

References (32)

1. ADA (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32(7): 1327-1334
2. Aderka D (1996) The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 7(3): 231-240
3. Balkwill F (2006) TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev 25(3): 409-416
4. Barber MD, Fearon KC, Ross JA (1999) Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer. Clin Sci (Lond) 96(1): 83-87 (Pubitemid 29045868)
5. Clendenen TV, Arslan AA, Lokshin AE, Idahl A, Hallmans G, Koenig KL, Marrangoni AM, Nolen BM, Ohlson N, Zeleniuch-Jacquotte A, Lundin E (2010) Temporal reliability of cytokines and growth factors in EDTA plasma. BMC Res Notes 3: 302
6. Douglas JB, Silverman DT, Weinstein SJ, Graubard BI, Pollak MN, Tao Y, Virtamo J, Albanes D, Stolzenberg-Solomon RZ (2010) Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studies. Cancer Epidemiol Biomarkers Prev 20(2): 359-369
7. Ebrahimi B, Tucker SL, Li D, Abbruzzese JL, Kurzrock R (2004) Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer 101(12): 2727-2736 (Pubitemid 39603180)
8. Farrow B, Evers BM (2002) Inflammation and the development of pancreatic cancer. Surg Oncol 10(4): 153-169 (Pubitemid 34520439)
9. Fernandez-Real JM, Broch M, Vendrell J, Ricart W (2003) Smoking, fat mass and activation of the tumor necrosis factor-alpha pathway. Int J Obes Relat Metab Disord 27(12): 1552-1556 (Pubitemid 38019171)
10. Forsythe LK, Wallace JM, Livingstone MB (2008) Obesity and inflammation: the effects of weight loss. Nutr Res Rev 21(2): 117-133
11. Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE, English DR, Folsom AR, Freudenheim JL, Fuchs CS, Giles GG, Giovannucci E, Horn-Ross PL, Larsson SC, Leitzmann M, Mannisto S, Marshall JR, Miller AB, Patel AV, Rohan TE, Stolzenberg-Solomon RZ, Verhage BA, Virtamo J, Willcox BJ, Wolk A, Ziegler RG, Smith-Warner SA (2010) A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer 29(7): 1708-1717
12. Goncalves RB, Coletta RD, Silvério KG, Benevides L, Casati MZ, da Silva JS, Nociti Jr FH (2011) Impact of smoking on inflammation: overview of molecular mechanisms. Inflamm Res 60(5): 409-424
13. Grote VA, Rohrmann S, Nieters A, Dossus L, Tjonneland A, Halkjaer J, Overvad K, Fagherazzi G, Boutron-Ruault MC, Morois S, Teucher B, Becker S, Sluik D, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Pala V, Tumino R, Vineis P, Panico S, Rodriguez L, Duell EJ, Molina-Montes E, Dorronsoro M, Huerta JM, Ardanaz E, Jeurnink SM, Beulens JW, Peeters PH, Sund M, Ye W, Lindkvist B, Johansen D, Khaw KT, Wareham N, Allen N, Crowe F, Jenab M, Romieu I, Michaud DS, Riboli E, Romaguera D, Bueno-de-Mesquita HB, Kaaks R (2011) Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia 54(12): 3037-3046
14. Gu Y, Zeleniuch-Jacquotte A, Linkov F, Koenig KL, Liu M, Velikokhatnaya L, Shore RE, Marrangoni A, Toniolo P, Lokshin AE, Arslan AA (2009) Reproducibility of serum cytokines and growth factors. Cytokine 45(1): 44-49
15. Haftenberger M, Lahmann PH, Panico S, Gonzalez CA, Seidell JC, Boeing H, Giurdanella MC, Krogh V, Bueno-de-Mesquita HB, Peeters PH, Skeie G, Hjartaker A, Rodriguez M, Quiros JR, Berglund G, Janlert U, Khaw KT, Spencer EA, Overvad K, Tjonneland A, Clavel-Chapelon F, Tehard B, Miller AB, Klipstein-Grobusch K, Benetou V, Kiriazi G, Riboli E, Slimani N (2002) Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 5(6B): 1147-1162 (Pubitemid 36313610)
16. Heikkilä K, Ebrahim S, Lawlor DA (2008) Systematic review of the association between circulating interleukin-6 (IL-6) and cancer. Eur J Cancer 44(7): 937-945
17. Himmerich H, Fulda S, Linseisen J, Seiler H, Wolfram G, Himmerich S, Gedrich K, Pollmacher T (2006) TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population. Eur Cytokine Netw 17(3): 196-201
18. Hodge DR, Hurt EM, Farrar WL (2005) The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 41(16): 2502-2512 (Pubitemid 41540626)
19. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444(7121): 860-867
20. Huxley R, Ansary-Moghaddam A, Berrington de González A, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a metaanalysis of 36 studies. Br J Cancer 92(11): 2076-2083
21. Kolb H, Mandrup-Poulsen T (2005) An immune origin of type 2 diabetes? Diabetologia 48(6): 1038-1050 (Pubitemid 40909636)
22. Lynch SM, Vrieling A, Lubin JH, Kraft P, Mendelsohn JB, Hartge P, Canzian F, Steplowski E, Arslan AA, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, Albanes D, Amundadottir L, Bingham SA, Boffetta P, Boutron-Ruault MC, Chanock SJ, Clipp S, Hoover RN, Jacobs K, Johnson KC, Kooperberg C, Luo J, Messina C, Palli D, Patel AV, Riboli E, Shu XO, Rodriguez Suarez L, Thomas G, Tjonneland A, Tobias GS, Tong E, Trichopoulos D, Virtamo J, Ye W, Yu K, Zeleniuch-Jacquette A, Bueno-de-Mesquita HB, Stolzenberg-Solomon RZ (2009) Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol 170(4): 403-413
23. McKay CJ, Glen P, McMillan DC (2008) Chronic inflammation and pancreatic cancer. Best Pract Res Clin Gastroenterol 22(1): 65-73
24. Moses AG, Maingay J, Sangster K, Fearon KC, Ross JA (2009) Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival. Oncol Rep 21(4): 1091-1095
25. Mroczko B, Groblewska M, Gryko M, Kedra B, Szmitkowski M (2010) Diagnostic usefulness of serum interleukin 6 (IL-6) and C-reactive protein (CRP) in the differentiation between pancreatic cancer and chronic pancreatitis. J Clin Lab Anal 24(4): 256-261
26. Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111(12): 1805-1812 (Pubitemid 38057722)
27. Raimondi S, Lowenfels AB, Morselli-Labate AM, Maisonneuve P, Pezzilli R (2010) Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 24(3): 349-358
28. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondière UR, Hémon B, Casagrande C, Vignat J, Overvad K, Tjønneland A, Clavel-Chapelon F, Thiébaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-De-Mesquita HB, Peeters PH, Lund E, Engeset D, González CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, Kaaks R, Saracci R (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5(6B): 1113-1124 (Pubitemid 36313608)
29. Talar-Wojnarowska R, Gasiorowska A, Smolarz B, Romanowicz-Makowska H, Kulig A, Malecka-Panas E (2009) Tumor necrosis factor alpha and interferon gamma genes polymorphisms and serum levels in pancreatic adenocarcinoma. Neoplasma 56(1): 56-62
30. Trichopoulos D, Psaltopoulou T, Orfanos P, Trichopoulou A, Boffetta P (2006) Plasma C-reactive protein and risk of cancer: a prospective study from Greece. Cancer Epidemiol Biomarkers Prev 15(2): 381-384 (Pubitemid 43348407)
31. Vrieling A, Bueno-de-Mesquita HB, Boshuizen HC, Michaud DS, Severinsen MT, Overvad K, Olsen A, Tjonneland A, Clavel-Chapelon F, Boutron-Ruault MC, Kaaks R, Rohrmann S, Boeing H, Nothlings U, Trichopoulou A, Moutsiou E, Dilis V, Palli D, Krogh V, Panico S, Tumino R, Vineis P, van Gils CH, Peeters PH, Lund E, Gram IT, Rodriguez L, Agudo A, Larranaga N, Sanchez MJ, Navarro C, Barricarte A, Manjer J, Lindkvist B, Sund M, Ye W, Bingham S, Khaw KT, Roddam A, Key T, Boffetta P, Duell EJ, Jenab M, Gallo V, Riboli E (2010) Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 126(10): 2394-2403
32. Whitcomb DC (2004) Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer. Am J Physiol Gastrointest Liver Physiol 287(2): G315-G319